æt kˈæmbiə, ænd wɪððɪ ɪnˈɪʃəl fˈʌndɪŋ ænd pˈɑːɹtnɚʃˌɪp wɪð ɹˈɑːkɪfəlɚ faʊndˈeɪʃənz ˈæɡɹɪkˌʌltʃɚ pɹˈoʊɡɹæm, dʒˈɛfɚsən ænd ðə kˈæmbiə stˈæf stˈɑːɹɾᵻd tə dɪvˈɛləp kˈiː nˈuː tˈuːlz ɪŋklˈuːdɪŋ ðə vˈɛktɚz, ɹᵻlˈiːst ɪn nˈaɪntiːnhˈʌndɹɪd nˈaɪnti sˈɛvən, ænd wˌɪtʃ nˈaʊ ɑːɹ ðə mˈoʊst wˈaɪdli jˈuːzd plˈæzmɪdz ɪn plˈænt bˌaɪoʊtɛknˈɑːlədʒi.
At Cambia, and with the initial funding and partnership with Rockefeller Foundation's agriculture program, Jefferson and the Cambia staff started to develop key new tools - including the  vectors, released in 1997, and which now are the most widely used plasmids in plant biotechnology.